• No results found

operable breast cancer

The decision making process for senior cancer patients: treatment allocation of older women with operable breast cancer in the UK

The decision making process for senior cancer patients: treatment allocation of older women with operable breast cancer in the UK

... with operable breast cancer should be treated with surgery, and not PET, “irrespective of age” unless this is precluded by comorbidities 14 ; whilst the International Society of Geriatric Oncology ...

14

The Effect of Overweight on The Risk of Recurrence in Tunisian Patients with Operable Breast Cancer

The Effect of Overweight on The Risk of Recurrence in Tunisian Patients with Operable Breast Cancer

... A negative impact for overweight at diagnosis on the outcome of breast cancer has been demonstrated in the literature. In our study, we found an inverse correlation between overweight and the risk of ...

6

Pathologic Response After Weekly Paclitaxel versus Docetaxel in Operable Breast Cancer

<p>Pathologic Response After Weekly Paclitaxel versus Docetaxel in Operable Breast Cancer</p>

... The bene fi t and safety of sequential neoadjuvant every 3 weeks Dtx at 100 mg/m 2 was compared to anthracy- clines only containing chemotherapy, in a randomized trial for operable breast cancer ...

8

Ambulatory sentinel lymph node biopsy preceding neoadjuvant therapy in patients with operable breast cancer: a preliminary study

Ambulatory sentinel lymph node biopsy preceding neoadjuvant therapy in patients with operable breast cancer: a preliminary study

... ing breast cancer surgery (BCS) is currently regarded as the standard minimally invasive strategy for managing clinically node-negative early breast cancer ...for operable breast ...

6

Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial

Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial

... with operable breast cancer should be treated with surgery, and not PET, “irrespective of age” unless this is precluded by co-morbidities [7]; whilst the International Society of Geriatric Oncology ...

30

High expression of metabolic enzyme PFKFB4 is associated with poor prognosis of operable breast cancer

High expression of metabolic enzyme PFKFB4 is associated with poor prognosis of operable breast cancer

... of cancer cell proliferation ...including breast cancer [6], prostate cancer [7] and glioma ...in breast cancer has not been ...

8

Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial

Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial

... While breast cancer outcomes are improving steadily in younger women due to advances in screening and improved therapies, there has been little change in outcomes among the older age ...some breast ...

9

Factors that predict recurrence later than 5 years after initial treatment in operable breast cancer

Factors that predict recurrence later than 5 years after initial treatment in operable breast cancer

... Patients with hormone receptor-positive breast cancer remain at risk of recurrence for as long as they survive. For that reason, many investigators have explored the benefit of extended therapy beyond the ...

8

Case mix does not fully explain variation in rates of non surgical treatment of older women with operable breast cancer

Case mix does not fully explain variation in rates of non surgical treatment of older women with operable breast cancer

... invasive breast cancers diagnosed in women aged 70 years and over between the years of 2002 and 2010 were acquired for two UK cancer registration regions (West Midlands, Northern and ...(excluding ...

12

Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial

Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial

... ER-positive breast cancer, and the decision regarding use of adjuvant chemotherapy in fitter women with high-risk ...detailed cancer registry outcome data linked to treatment-related morbidity and ...

9

Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial

Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial

... While breast cancer outcomes are improving steadily in younger women due to advances in screening and improved therapies, there has been little change in outcomes among the older age ...some breast ...

11

Window of opportunity Study Testing the Antiproliferative Effect of Atorvastatin in Egyptian Patients with Operable Breast Cancer

Window of opportunity Study Testing the Antiproliferative Effect of Atorvastatin in Egyptian Patients with Operable Breast Cancer

... as breast cancer by true cut biopsy and tumor proliferation was measured before the start of statin treatment, after that, all patients received atorvastatin 80mg /day for at least 14 days, then subjected ...

7

Hypothyroidism and the risk of breast cancer recurrence and all cause mortality   a Danish population based study

Hypothyroidism and the risk of breast cancer recurrence and all cause mortality a Danish population based study

... I-III, operable breast cancer on protocol treatment and diagnosed between January 1, 1996, and December 31, 2009 ...improve breast cancer prognosis [25]. All patients with invasive ...

11

Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group

Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group

... early breast cancer patients, enrolled in two prospective phase III ...high-risk operable breast cancer, comparing four cycles of epirubicin (E) followed by four cycles of intensified ...

11

HER2 and TOP2A in high risk early breast cancer patients treated with adjuvant epirubicin based dose dense sequential chemotherapy

HER2 and TOP2A in high risk early breast cancer patients treated with adjuvant epirubicin based dose dense sequential chemotherapy

... Based upon this information we performed a compre- hensive evaluation of HER2 and TOP2A parameters in tumors from patients that had participated in the Helle- nic Cooperative Oncology Group (HeCOG) phase III trial ...

21

Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus)

Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus)

... The trend towards primary tamoxifen treatment was based on the premise that older women are less likely to be fit for surgery. The incidence of significant co-morbidity is greater in the elderly (Satariano 1994), which ...

36

A Study on incidence of operable carcinoma breast

A Study on incidence of operable carcinoma breast

... Breast cancer may arise from the epithelium of the duct system anywhere from the nipple end of major lactiferous ducts to the terminal duct unit, which is in the breast ...of breast ...

100

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.

... German Breast Group, Neu-Isenburg, Germany ...the Breast European Adjuvant Study Team (BrEAST) Data Center ...the Breast Interna- tional Group ...Dana–Farber Cancer Institute, Harvard ...

10

Feasibility of Concurrent Radiotherapy and Paclitaxel Based Chemotherapy after Conservative Surgery for Breast Cancer

Feasibility of Concurrent Radiotherapy and Paclitaxel Based Chemotherapy after Conservative Surgery for Breast Cancer

... with breast cancer in the period from May 2014 to November ...Egypt Cancer Institute, Assiut Univer- ...the breast; pT1-2, and pN1-3, M0, Age ≥ 18 and ≤70; PS ≤ 2 (ECOG), underwent BCS with ...

11

Prognostic Significance of Architectural Invasive and Proliferative features in Invasive Breast Carcinoma.

Prognostic Significance of Architectural Invasive and Proliferative features in Invasive Breast Carcinoma.

... In a study of nine putative prognostic factors in nearly 400 patients with primary operable breast cancer, Haybittle JL, et al., (1982) found that several showed a significant relationship to ...

85

Show all 10000 documents...

Related subjects